MedPath
NMPA Approval

Salbutamol Sulfate Inhalation Solution

国药准字HJ20250059

May 27, 2025

Drug Information

吸入用硫酸沙丁胺醇溶液

吸入制剂

2.5ml:5mg(按C₁₃H₂₁NO₃ 计)

化学药品

May 27, 2025

May 26, 2030

Company Information

Applicant Company

TEVA UK LIMITED

RIDINGS POINT, WHISTLER DRIVE, CASTLEFORD, WF10 5HX, UNITED KINGDOM

Manufacturing Company

norton healthcare limited t/a ivax pharmaceuticals uk

ASTON LANE NORTH,WHITEHOUSE VALE INDUSTRIAL ESTATE,PRESTON BROOK, RUNCORN,WA7 3FA,UNITED KINGDOM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吸入用硫酸沙丁胺醇溶液 - NMPA 批准文号 | MedPath